Cargando…

Kinectin 1 promotes the growth of triple-negative breast cancer via directly co-activating NF-kappaB/p65 and enhancing its transcriptional activity

Triple-negative breast cancer (TNBC) is the most challenging subtype of breast cancer. Various endeavor has been made to explore the molecular biology basis of TNBC. Herein, we reported a novel function of factor Kinectin 1 (KTN1) as a carcinogenic promoter in TNBC. KTN1 expression in TNBC was incre...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Lin, Chen, Shanze, Hong, Malin, Zhou, Wenbin, Wang, Bilan, Qiu, Junying, Xia, Jinquan, Zhao, Pan, Fu, Li, Wang, Jigang, Dai, Yong, Xie, Ni, Yang, Qinhe, Huang, Hsien-Da, Gao, Xiang, Zou, Chang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255318/
https://www.ncbi.nlm.nih.gov/pubmed/34219129
http://dx.doi.org/10.1038/s41392-021-00652-x
_version_ 1783717880374755328
author Gao, Lin
Chen, Shanze
Hong, Malin
Zhou, Wenbin
Wang, Bilan
Qiu, Junying
Xia, Jinquan
Zhao, Pan
Fu, Li
Wang, Jigang
Dai, Yong
Xie, Ni
Yang, Qinhe
Huang, Hsien-Da
Gao, Xiang
Zou, Chang
author_facet Gao, Lin
Chen, Shanze
Hong, Malin
Zhou, Wenbin
Wang, Bilan
Qiu, Junying
Xia, Jinquan
Zhao, Pan
Fu, Li
Wang, Jigang
Dai, Yong
Xie, Ni
Yang, Qinhe
Huang, Hsien-Da
Gao, Xiang
Zou, Chang
author_sort Gao, Lin
collection PubMed
description Triple-negative breast cancer (TNBC) is the most challenging subtype of breast cancer. Various endeavor has been made to explore the molecular biology basis of TNBC. Herein, we reported a novel function of factor Kinectin 1 (KTN1) as a carcinogenic promoter in TNBC. KTN1 expression in TNBC was increased compared with adjacent tissues or luminal or Her2 subtypes of breast cancer, and TNBC patients with high KTN1 expression have poor prognosis. In functional studies, knockdown of KTN1 inhibited the proliferation and invasiveness of TNBC both in vitro and in vivo, while overexpression of KTN1 promoted cancer cell proliferation and invasiveness. RNA-seq analysis revealed that the interaction of cytokine-cytokine receptor, particularly CXCL8 gene, was upregulated by KTN1, which was supported by the further experiments. CXCL8 depletion inhibited the tumorigenesis and progression of TNBC. Additionally, rescue experiments validated that KTN1-mediated cell growth acceleration in TNBC was dependent on CXCL8 both in vitro and in vivo. Furthermore, it was found that KTN1 enhanced the phosphorylation of NF-κB/p65 protein at Ser536 site, and specifically bound to NF-κB/p65 protein in the nucleus and cytoplasm of cells. Moreover, the transcription of CXCL8 gene was directly upregulated by the complex of KTN1 and NF-κB/p65 protein. Taken together, our results elucidated a novel mechanism of KTN1 gene in TNBC tumorigenesis and progression. KTN1 may be a potential molecular target for the development of TNBC treatment.
format Online
Article
Text
id pubmed-8255318
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-82553182021-07-20 Kinectin 1 promotes the growth of triple-negative breast cancer via directly co-activating NF-kappaB/p65 and enhancing its transcriptional activity Gao, Lin Chen, Shanze Hong, Malin Zhou, Wenbin Wang, Bilan Qiu, Junying Xia, Jinquan Zhao, Pan Fu, Li Wang, Jigang Dai, Yong Xie, Ni Yang, Qinhe Huang, Hsien-Da Gao, Xiang Zou, Chang Signal Transduct Target Ther Article Triple-negative breast cancer (TNBC) is the most challenging subtype of breast cancer. Various endeavor has been made to explore the molecular biology basis of TNBC. Herein, we reported a novel function of factor Kinectin 1 (KTN1) as a carcinogenic promoter in TNBC. KTN1 expression in TNBC was increased compared with adjacent tissues or luminal or Her2 subtypes of breast cancer, and TNBC patients with high KTN1 expression have poor prognosis. In functional studies, knockdown of KTN1 inhibited the proliferation and invasiveness of TNBC both in vitro and in vivo, while overexpression of KTN1 promoted cancer cell proliferation and invasiveness. RNA-seq analysis revealed that the interaction of cytokine-cytokine receptor, particularly CXCL8 gene, was upregulated by KTN1, which was supported by the further experiments. CXCL8 depletion inhibited the tumorigenesis and progression of TNBC. Additionally, rescue experiments validated that KTN1-mediated cell growth acceleration in TNBC was dependent on CXCL8 both in vitro and in vivo. Furthermore, it was found that KTN1 enhanced the phosphorylation of NF-κB/p65 protein at Ser536 site, and specifically bound to NF-κB/p65 protein in the nucleus and cytoplasm of cells. Moreover, the transcription of CXCL8 gene was directly upregulated by the complex of KTN1 and NF-κB/p65 protein. Taken together, our results elucidated a novel mechanism of KTN1 gene in TNBC tumorigenesis and progression. KTN1 may be a potential molecular target for the development of TNBC treatment. Nature Publishing Group UK 2021-07-05 /pmc/articles/PMC8255318/ /pubmed/34219129 http://dx.doi.org/10.1038/s41392-021-00652-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Gao, Lin
Chen, Shanze
Hong, Malin
Zhou, Wenbin
Wang, Bilan
Qiu, Junying
Xia, Jinquan
Zhao, Pan
Fu, Li
Wang, Jigang
Dai, Yong
Xie, Ni
Yang, Qinhe
Huang, Hsien-Da
Gao, Xiang
Zou, Chang
Kinectin 1 promotes the growth of triple-negative breast cancer via directly co-activating NF-kappaB/p65 and enhancing its transcriptional activity
title Kinectin 1 promotes the growth of triple-negative breast cancer via directly co-activating NF-kappaB/p65 and enhancing its transcriptional activity
title_full Kinectin 1 promotes the growth of triple-negative breast cancer via directly co-activating NF-kappaB/p65 and enhancing its transcriptional activity
title_fullStr Kinectin 1 promotes the growth of triple-negative breast cancer via directly co-activating NF-kappaB/p65 and enhancing its transcriptional activity
title_full_unstemmed Kinectin 1 promotes the growth of triple-negative breast cancer via directly co-activating NF-kappaB/p65 and enhancing its transcriptional activity
title_short Kinectin 1 promotes the growth of triple-negative breast cancer via directly co-activating NF-kappaB/p65 and enhancing its transcriptional activity
title_sort kinectin 1 promotes the growth of triple-negative breast cancer via directly co-activating nf-kappab/p65 and enhancing its transcriptional activity
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255318/
https://www.ncbi.nlm.nih.gov/pubmed/34219129
http://dx.doi.org/10.1038/s41392-021-00652-x
work_keys_str_mv AT gaolin kinectin1promotesthegrowthoftriplenegativebreastcancerviadirectlycoactivatingnfkappabp65andenhancingitstranscriptionalactivity
AT chenshanze kinectin1promotesthegrowthoftriplenegativebreastcancerviadirectlycoactivatingnfkappabp65andenhancingitstranscriptionalactivity
AT hongmalin kinectin1promotesthegrowthoftriplenegativebreastcancerviadirectlycoactivatingnfkappabp65andenhancingitstranscriptionalactivity
AT zhouwenbin kinectin1promotesthegrowthoftriplenegativebreastcancerviadirectlycoactivatingnfkappabp65andenhancingitstranscriptionalactivity
AT wangbilan kinectin1promotesthegrowthoftriplenegativebreastcancerviadirectlycoactivatingnfkappabp65andenhancingitstranscriptionalactivity
AT qiujunying kinectin1promotesthegrowthoftriplenegativebreastcancerviadirectlycoactivatingnfkappabp65andenhancingitstranscriptionalactivity
AT xiajinquan kinectin1promotesthegrowthoftriplenegativebreastcancerviadirectlycoactivatingnfkappabp65andenhancingitstranscriptionalactivity
AT zhaopan kinectin1promotesthegrowthoftriplenegativebreastcancerviadirectlycoactivatingnfkappabp65andenhancingitstranscriptionalactivity
AT fuli kinectin1promotesthegrowthoftriplenegativebreastcancerviadirectlycoactivatingnfkappabp65andenhancingitstranscriptionalactivity
AT wangjigang kinectin1promotesthegrowthoftriplenegativebreastcancerviadirectlycoactivatingnfkappabp65andenhancingitstranscriptionalactivity
AT daiyong kinectin1promotesthegrowthoftriplenegativebreastcancerviadirectlycoactivatingnfkappabp65andenhancingitstranscriptionalactivity
AT xieni kinectin1promotesthegrowthoftriplenegativebreastcancerviadirectlycoactivatingnfkappabp65andenhancingitstranscriptionalactivity
AT yangqinhe kinectin1promotesthegrowthoftriplenegativebreastcancerviadirectlycoactivatingnfkappabp65andenhancingitstranscriptionalactivity
AT huanghsienda kinectin1promotesthegrowthoftriplenegativebreastcancerviadirectlycoactivatingnfkappabp65andenhancingitstranscriptionalactivity
AT gaoxiang kinectin1promotesthegrowthoftriplenegativebreastcancerviadirectlycoactivatingnfkappabp65andenhancingitstranscriptionalactivity
AT zouchang kinectin1promotesthegrowthoftriplenegativebreastcancerviadirectlycoactivatingnfkappabp65andenhancingitstranscriptionalactivity